Avastin Sales Data

Rank 17 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Avastin U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 17 (1) -1.25% 0.22%
Q3 2013 16 -1.41% -4.22%
Q2 2013 16 4.22% 2.60%
Q1 2013 16 1.04%
Q4 2012 16 -2.49% -2.12%
Q3 2012 16 (2) 0.41% -0.84%
Q2 2012 18 (2) 2.46% 3.48%
Q1 2012 20 (1) -1.92% -2.13%
Q4 2011 21 2.86% 3.52%
Q3 2011 21 -3.57% -3.61%
Q2 2011 21 -1.29% -0.63%
Q1 2011 21

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
August 15, 2014Turkish man pleads guilty to importing illegal cancer drugs
August 15, 2014Avastin Approved for Late-Stage Cervical Cancer
February 19, 2014Avastin Shows Mixed Results Against Different Cancers
August 19, 2013Study: Brain Cancer Survival Improved Following FDA Approval of Avastin
July 19, 2013Cheaper Cancer Drug Could be Used to Treat Eye Disorder
March 20, 2013Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection
February 29, 2012Health Highlights: Feb. 29, 2012
February 17, 2012US Industry Bickers Over How to Capture Fake Drugs
December 28, 2011Avastin May Help Some With Ovarian Cancer: Studies
December 7, 2011Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study
July 1, 2011Avastin Rejection Supported by Cancer Experts
June 29, 2011Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer
June 29, 2011FDA Panel Rejects Avastin for Breast Cancer
June 28, 2011FDA to Hear Appeal on Breast Cancer Drug
June 9, 2011Chemo for Late-Stage Cancer Patients May Be Unjustified
June 4, 2011Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
February 1, 2011More Evidence Cancer Drug Avastin May Cause Harm
January 4, 2011More Evidence Links Avastin to Heart Failure in Breast Cancer Patients
December 16, 2010FDA Advises Against Avastin as Treatment for Breast Cancer
December 16, 2010FDA Begins Process to Remove Breast Cancer Indication from Avastin Label
December 16, 2010Genentech Provides Update on Avastin for Metastatic Breast Cancer Following Reviews in Europe and the United States
July 20, 2010US Panel: Study Showed No Benefit With Avastin
July 20, 2010FDA Advisers Say Avastin Shouldn't Be Used for Breast Cancer
July 20, 2010Avastin Largely Safe for Patients With Type of Advanced Lung Cancer
March 12, 2010Genentech Says Avastin Trial Did Not Meet Goal
December 1, 2009CT Scan May Predict Colon Cancer Survival
August 5, 2009Scientists Learn How Cancer Drugs Cause Hypertension
August 4, 2009FDA Approves Avastin for Most Common Kidney Cancer
July 30, 2009Brain Scan May Help Predict Cancer Drug Response
May 30, 2009Drug Combo Proves Powerful Against Lung Cancer
May 30, 2009Avastin Shows No Benefit Against Early Stage Colon Cancer
May 25, 2009Cancer Drug May Boost Risk of Gastrointestinal Perforation
May 7, 2009Avastin Gets New Approval for Brain Cancer
March 31, 2009FDA Advisory Committee Unanimously Recommends Accelerated Approval of Avastin for Previously Treated Brain Cancer (Glioblastoma)
November 18, 2008Cancer Drug Ups Risk of Clots in Veins
July 14, 2008FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports of Microangiopathic Hemolytic Anemia In Patients Treated With This Combination
Hide
(web5)